Christopher Regan is an Executive Director in Safety & Exploratory Pharmacology at Merck, where they lead a team focused on developing nonclinical safety pharmacology models to enhance drug development decisions. With over 20 years of experience in pharmaceutical research, they have held various roles, including postdoctoral fellow at the University of Virginia and positions at Vertex Pharmaceuticals. Christopher completed a PhD in Physiology and Biophysics from the University of Alabama at Birmingham and has contributed significantly to cardiovascular and neurodegenerative research, driving innovation in drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices